Publicacions destacades

• BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system

  Reig M; Forner A; Rimola J; Ferrer-Fábrega J; Burrel M;

  (...)

  Singal AG; Vogel A; Fuster J; Ayuso C; Bruix J .

  Veure llistat complet d'autors

  Referència:

  Journal Of Hepatology 2022.

• Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis

  Sapena V; Enea M; Torres F; Celsa C; Rios J;

  (...)

  Trevisani F; Cammà C; Bruix J; Cabibbo G; Reig M .

  Veure llistat complet d'autors

  Referència:

  Gut 2022.

• Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules

  Sanduzzi-Zamparelli M; Mariño Z; Lens S; Sapena V; Iserte G;

  (...)

  Forner A; Torres F; Bruix J; Forns X; Reig M .

  Veure llistat complet d'autors

  Referència:

  Journal Of Hepatology 2022.

• Antiviral therapy in the palliative setting of HCC (BCLC B and C)

  Reig M; Cabibbo G ;

  Referència:

  Journal Of Hepatology 2021.

• Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

  Corominas J; Sapena V; Sanduzzi-Zamparelli M; Millán C; Samper E;

  (...)

  Muñoz-Martínez S; Forner A; Bruix J; Boix L; Reig M .

  Veure llistat complet d'autors

  Referència:

  Cancers 2021.

• Regorafenib efficacy after sorafenib in patients with recurrent HCC after liver transplantation: a retrospective study

  Iavarone M; Invernizzi F; Ivanics T; Mazza S; Zavaglia C;

  (...)

  Wörns MA; Bruix J; Sapisochin G; Lampertico P; Reig M .

  Veure llistat complet d'autors

  Referència:

  Liver Transplantation 2021.

• Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

  Iavarone M; Invernizzi F; Czauderna C; Sanduzzi-Zamparelli M; Bhoori S;

  (...)

  Varela M; Wörns MA; Bruix J; Lampertico P; Reig M .

  Veure llistat complet d'autors

  Referència:

  American Journal Of Transplantation 2019.

• Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: relevance of non-characterized nodules

  Mariño Z; Darnell A; Lens S; Sapena V; Díaz A;

  (...)

  Ayuso C; Ríos J; Forns X; Bruix J; Reig M .

  Veure llistat complet d'autors

  Referència:

  Journal Of Hepatology 2019.

• New trials and results in systemic treatment of HCC.

  Reig M; da Fonseca LG; Faivre S ;

  Referència:

  Journal Of Hepatology 2018.

• Complete response under sorafenib in patients with hepatocellular carcinoma. Relationship with dermatologic adverse events.

  Rimola J; Díaz-González Á; Darnell A; Varela M; Pons F;

  (...)

  Huertas C; Minguez B; Ayuso C; Bruix J; Reig M .

  Veure llistat complet d'autors

  Referència:

  Hepatology 2018.